Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients-Reference-Cited by-同舟云学术

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients

Published:2007-06-18 Issue:27 Volume:104 Page:11406-11411
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Pellagatti A.,Jadersten M.,Forsblom A.-M.,Cattan H.,Christensson B.,Emanuelsson E. K.,Merup M.,Nilsson L.,Samuelsson J.,Sander B.,Wainscoat J. S.,Boultwood J.,Hellstrom-Lindberg E.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference64 articles.

1. Myelodysplasia

2. Distinct haematological disorder with deletion of long arm of No. 5 chromosome

3. The 5q-syndrome

4. Efficacy of Lenalidomide in Myelodysplastic Syndromes

5. Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion

Cited by 213 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell transcriptional profile of CD34+ hematopoietic progenitor cells from del(5q) myelodysplastic syndromes and impact of lenalidomide;Nature Communications;2024-06-20

2. A Brief Overview of the Molecular Landscape of Myelodysplastic Neoplasms;Current Oncology;2024-04-23

3. Improved Side Effect Profile of Alternate-Day Dosing of Lenalidomide;Cureus;2024-03-01

4. Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications;European Journal of Haematology;2024-01-31

5. The role of lymphoid tissue SPARC in the pathogenesis and response to treatment of multiple myeloma;Frontiers in Oncology;2022-12-20